Bio-Rad Laboratories Inc. (BIO)

Bio-Rad Laboratories Inc. Borsa (BIO) Ultime notizie

BNP Paribas Financial Markets Buys 12,662 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat

MarketBeat

Bio-Rad Appoints John Goetz as Chief Operating Officer and Announces Other Executive Appointments - Yahoo Movies UK

Yahoo Movies UK

Chromatography Resins Market 2024 Size, Global Report till 2031 | Bio-Rad Laboratories Inc, GE Healthcare Life ... - openPR

openPR

Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by Victory Capital Management Inc. - Defense World

Defense World

5,163 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Purchased by Jump Financial LLC - MarketBeat

MarketBeat

Genomics Market Detailed In New Research Report 2024 | Bio-Rad Laboratories, Inc., Illumina, Inc., Pacific ... - openPR

openPR

Oncology Liquid Biopsy (LBx) Market Analysis, Research Study With Bio-Rad Laboratories, Biocept Inc., Guardant Health - openPR

openPR

Here's Why You Should Retain Bio-Rad (BIO) Stock for Now - Yahoo Singapore News

Yahoo Singapore News

Point-of-Care Diagnostics Global Report 2024-2030 Featuring Sysmex, Abbott Laboratories, BD and Co, Danaher ... - Manchestertimes

Manchestertimes

Macrophage Marker Market to See Booming Growth 2024-2031 | Abcam plc, Bio-Rad Laboratories, GeneTex, Inc, - EIN News

EIN News

Bio-Rad Laboratories (NYSE:BIO.B) Shares Down 17.3% - MarketBeat

MarketBeat

M&T Bank Corp Reduces Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World

Defense World

Roubaix Capital LLC Makes New $4.05 Million Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat

MarketBeat

Here's Why You Should Invest in Bio-Rad (BIO) Stock Now - Yahoo Lifestyle Australia

Yahoo Lifestyle Australia

Here's Why You Should Retain Bio-Rad (BIO) Stock for Now - Yahoo New Zealand News

Yahoo New Zealand News

Electrophoresis Reagents Market Size 2024-2031: Industrial Overv - SOUTHEAST - News Channel Nebraska

News Channel Nebraska

Bio-Rad Laboratories, Inc. (NYSE:BIO) Holdings Lowered by Metis Global Partners LLC - Defense World

Defense World

Mawer Investment Management Ltd. Sells 38,954 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat

MarketBeat

Russell Investments Group Ltd. Has $4.91 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World

Defense World

Bio-Rad Laboratories (NYSE:BIO) PT Lowered to $385.00 at UBS Group - Defense World

Defense World

Natixis Advisors L.P. Increases Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat

MarketBeat

Wall Street Analysts Predict a 28.56% Upside in Bio-Rad (BIO): Here's What You Should Know - Yahoo Movies UK

Yahoo Movies UK

Natixis Advisors L.P. Grows Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World

Defense World

Here's What Analysts Are Forecasting For Bio-Rad Laboratories, Inc. (NYSE:BIO) After Its First-Quarter Results - Yahoo Finance

Yahoo Finance

Blood Group Typing Technology Market 2023-2030 Insight View with Size and Growth Analysis | Research Report by ... - News Channel Nebraska

News Channel Nebraska

Genomics Market Size and Share 2023-2030 Detailed Analysis by Regions, Countries, Types, Applications and ... - News Channel Nebraska

News Channel Nebraska

Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Swiss National Bank - Defense World

Defense World

Swiss National Bank Decreases Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat

MarketBeat

Retirement Systems of Alabama Has $1.49 Million Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World

Defense World

Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip - Yahoo News Canada

Yahoo News Canada

Here's Why You Should Invest in Bio-Rad (BIO) Stock Now - Yahoo News Australia

Yahoo News Australia

Bio-Rad Laboratories Up 7% After Investor Day - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Bio-Rad Laboratories (NYSE:BIO) Releases Earnings Results, Beats Expectations By $0.25 EPS - MarketBeat

MarketBeat

Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down to $338.55 - MarketBeat

MarketBeat

UBS Group Trims Bio-Rad Laboratories (NYSE:BIO) Target Price to $385.00 - MarketBeat

MarketBeat

Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down - Zacks Investment Research

Zacks Investment Research

Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down - Yahoo Finance UK

Yahoo Finance UK

Bio-Rad Laboratories is Now Oversold (BIO) - Nasdaq

Nasdaq

The Analyst Landscape: 4 Takes On Bio-Rad Laboratories - Bio-Rad Laboratories (NYSE:BIO) - Benzinga

Benzinga

BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024 - MSN

MSN

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript - Yahoo Finance Australia

Yahoo Finance Australia

Bio-Rad Expands Range of Antibody Markers - Lab Manager Magazine

Lab Manager Magazine

Earnings call: Bio-Rad sees decline in Q1 sales but maintains full-year outlook - Investing.com

Investing.com

Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down - Zacks Investment Research

Zacks Investment Research

BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024 - InvestorPlace

InvestorPlace

BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024 - TradingView

TradingView

Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates - Zacks Investment Research

Zacks Investment Research

Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates - Yahoo Finance UK

Yahoo Finance UK

Truist Financial Corp Cuts Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat

MarketBeat